Danielle Ellis

Danielle Ellis

Editor-in-Chief

Biological Sciences, B.Sc.

Danielle graduated with a 2:1 in Biological Sciences with a Professional Training Year from Cardiff University. During her Professional Training Year, Danielle worked with the registered charity the Frozen Ark Project, creating and promoting various forms of content within their brand guidelines.

See more

Since joining AZoNetwork and becoming an editor on News-Medical, Danielle has completed an HMX Fundamentals Program from Harvard Medical School and earned a Certificate of Completion in Immunology.

Danielle has a great appreciation and passion for science communication and enjoys reading non-fiction and fiction in her spare time. Her other interests include doing yoga, collecting vinyl, and visiting museums.

See less

Articles from Danielle

Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence Prevention

Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence Prevention

World Immunization Week 2022: Gavi, The Vaccine Alliance on the equitable and sustainable use of vaccines

World Immunization Week 2022: Gavi, The Vaccine Alliance on the equitable and sustainable use of vaccines

Highly Effective Single-Dose HPV Vaccination for the Eradication of Cervical Cancer

Highly Effective Single-Dose HPV Vaccination for the Eradication of Cervical Cancer

Discovering Genetic Variants that Significantly Predispose People to Critical COVID-19

Discovering Genetic Variants that Significantly Predispose People to Critical COVID-19

Period Poverty in a Pandemic

Period Poverty in a Pandemic

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

International Women's Day 2022: Breaking the Bias

International Women's Day 2022: Breaking the Bias

Mapping cells to understand vascular disease

Mapping cells to understand vascular disease

Study suggests non-classical inhibition of TBK1/IKKε is protective against severe COVID-19 immunopathology in vivo

Study suggests non-classical inhibition of TBK1/IKKε is protective against severe COVID-19 immunopathology in vivo

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.